
Mary Mosher
Examiner (ID: 10578)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1641, 1805, 2899, 1813, 1648, 1804, 1643, 1815, 1609 |
| Total Applications | 1434 |
| Issued Applications | 907 |
| Pending Applications | 126 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6918021
[patent_doc_number] => 20050095582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Compositions and methods for detecting severe acute respiratory syndrome coronavirus'
[patent_app_type] => utility
[patent_app_number] => 10/699936
[patent_app_country] => US
[patent_app_date] => 2003-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 86
[patent_figures_cnt] => 86
[patent_no_of_words] => 36795
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10699936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/699936 | Compositions and methods for detecting severe acute respiratory syndrome coronavirus | Nov 2, 2003 | Issued |
Array
(
[id] => 7199275
[patent_doc_number] => 20040086489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Methods and compositions useful for stimulating an immune response'
[patent_app_type] => new
[patent_app_number] => 10/681478
[patent_app_country] => US
[patent_app_date] => 2003-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17015
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086489.pdf
[firstpage_image] =>[orig_patent_app_number] => 10681478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/681478 | Methods and compositions useful for stimulating an immune response | Oct 7, 2003 | Abandoned |
Array
(
[id] => 5637418
[patent_doc_number] => 20060068391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Targeting of herpes simplex virus to specific receptors'
[patent_app_type] => utility
[patent_app_number] => 10/530774
[patent_app_country] => US
[patent_app_date] => 2003-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10589
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20060068391.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530774
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530774 | Targeting of herpes simplex virus to specific receptors | Oct 5, 2003 | Issued |
Array
(
[id] => 4751884
[patent_doc_number] => 20080159957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Anti-Cancer and Anti-Infectious Disease Compositions and Methods for Using Same'
[patent_app_type] => utility
[patent_app_number] => 10/530000
[patent_app_country] => US
[patent_app_date] => 2003-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 22170
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20080159957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530000 | Anti-Cancer and Anti-Infectious Disease Compositions and Methods for Using Same | Sep 30, 2003 | Abandoned |
Array
(
[id] => 7349164
[patent_doc_number] => 20040047836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Anti-neoplastic viral agents'
[patent_app_type] => new
[patent_app_number] => 10/376630
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14728
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20040047836.pdf
[firstpage_image] =>[orig_patent_app_number] => 10376630
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/376630 | Anti-neoplastic viral agents | Sep 28, 2003 | Issued |
| 10/670788 | Animal cells and processes for the replication of influenza viruses | Sep 25, 2003 | Abandoned |
Array
(
[id] => 609154
[patent_doc_number] => 07150874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-19
[patent_title] => 'Vector for integration of heterologous sequences into poxviral genomes'
[patent_app_type] => utility
[patent_app_number] => 10/668521
[patent_app_country] => US
[patent_app_date] => 2003-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4018
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/150/07150874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10668521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/668521 | Vector for integration of heterologous sequences into poxviral genomes | Sep 22, 2003 | Issued |
Array
(
[id] => 7280377
[patent_doc_number] => 20040062754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Photopheresis treatment of chronic HCV infections'
[patent_app_type] => new
[patent_app_number] => 10/665446
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6261
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20040062754.pdf
[firstpage_image] =>[orig_patent_app_number] => 10665446
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/665446 | Photopheresis treatment of chronic HCV infections | Sep 18, 2003 | Abandoned |
Array
(
[id] => 7033529
[patent_doc_number] => 20050032038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Methods of identifying anti-viral agents'
[patent_app_type] => utility
[patent_app_number] => 10/657399
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11490
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10657399
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/657399 | Methods of identifying anti-viral agents | Sep 7, 2003 | Abandoned |
Array
(
[id] => 314539
[patent_doc_number] => 07524508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Subgenomic replicons of the flavivirus dengue'
[patent_app_type] => utility
[patent_app_number] => 10/656721
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 20
[patent_no_of_words] => 15674
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524508.pdf
[firstpage_image] =>[orig_patent_app_number] => 10656721
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/656721 | Subgenomic replicons of the flavivirus dengue | Sep 4, 2003 | Issued |
Array
(
[id] => 7457267
[patent_doc_number] => 20040197346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Materials and methods for intracellular transport and their uses'
[patent_app_type] => new
[patent_app_number] => 10/654869
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9609
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197346.pdf
[firstpage_image] =>[orig_patent_app_number] => 10654869
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/654869 | Materials and methods for intracellular transport and their uses | Sep 2, 2003 | Abandoned |
Array
(
[id] => 5747472
[patent_doc_number] => 20060110403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Non-human herpesviruses as vectors'
[patent_app_type] => utility
[patent_app_number] => 10/526354
[patent_app_country] => US
[patent_app_date] => 2003-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11291
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526354
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526354 | Non-human herpesviruses as vectors | Aug 31, 2003 | Abandoned |
Array
(
[id] => 7216768
[patent_doc_number] => 20040071734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Novel vaccine'
[patent_app_type] => new
[patent_app_number] => 10/469191
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14061
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20040071734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10469191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/469191 | Novel vaccine | Aug 24, 2003 | Abandoned |
Array
(
[id] => 7421560
[patent_doc_number] => 20040229211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => ' Sensitive diagnostic testing methodology using multiplex real time PCR with one dye (MOD) and its use as in severe acute respiratory syndrome (SARS)'
[patent_app_type] => new
[patent_app_number] => 10/455043
[patent_app_country] => US
[patent_app_date] => 2003-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4407
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229211.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455043 | Sensitive diagnostic testing methodology using multiplex real time PCR with one dye (MOD) and its use as in severe acute respiratory syndrome (SARS) | Aug 21, 2003 | Abandoned |
Array
(
[id] => 6971628
[patent_doc_number] => 20050037338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Method and means for detection of severe acute respiratory syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/640032
[patent_app_country] => US
[patent_app_date] => 2003-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3264
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037338.pdf
[firstpage_image] =>[orig_patent_app_number] => 10640032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/640032 | Method and means for detection of severe acute respiratory syndrome | Aug 13, 2003 | Abandoned |
Array
(
[id] => 6678434
[patent_doc_number] => 20030228575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Combination of circulating epstein-barr virus (EBV) DNA in the serum or plasma of patients and a method to assess EBV subtypes for the prediction and detection of epstein-barr virus associated cancers'
[patent_app_type] => new
[patent_app_number] => 10/455041
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4912
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228575.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455041 | Combination of circulating epstein-barr virus (EBV) DNA in the serum or plasma of patients and a method to assess EBV subtypes for the prediction and detection of epstein-barr virus associated cancers | Aug 7, 2003 | Abandoned |
Array
(
[id] => 7352619
[patent_doc_number] => 20040048383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex'
[patent_app_type] => new
[patent_app_number] => 10/634862
[patent_app_country] => US
[patent_app_date] => 2003-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 8058
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048383.pdf
[firstpage_image] =>[orig_patent_app_number] => 10634862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/634862 | Method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex | Aug 5, 2003 | Issued |
Array
(
[id] => 7060982
[patent_doc_number] => 20050003343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 10/634961
[patent_app_country] => US
[patent_app_date] => 2003-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20077
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10634961
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/634961 | Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents | Aug 4, 2003 | Issued |
Array
(
[id] => 7152623
[patent_doc_number] => 20050025781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/630070
[patent_app_country] => US
[patent_app_date] => 2003-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 41978
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20050025781.pdf
[firstpage_image] =>[orig_patent_app_number] => 10630070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/630070 | Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof | Jul 29, 2003 | Issued |
Array
(
[id] => 7024954
[patent_doc_number] => 20050019348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Marek\'s disease virus vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/623891
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6167
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019348.pdf
[firstpage_image] =>[orig_patent_app_number] => 10623891
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/623891 | Marek's disease virus vaccine | Jul 20, 2003 | Abandoned |